Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to (18)F–FDG-PET/CT

BACKGROUND: Gastro-intestinal stromal tumors (GISTs) are very rare tumors of the gastro-intestinal tract, originating from the interstitial cells of Cajal or a common cell precursor which both express type III tyrosine kinase receptors. Regorafenib is an oral multi-kinase inhibitor used to treat gas...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Weehaeghe, Donatienne, Gheysens, Olivier, Vandecaveye, Vincent, Schöffski, Patrick, Van Laere, Koen, Deroose, Christophe M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836457/
https://www.ncbi.nlm.nih.gov/pubmed/29506493
http://dx.doi.org/10.1186/s12885-018-4154-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836457/
https://www.ncbi.nlm.nih.gov/pubmed/29506493
http://dx.doi.org/10.1186/s12885-018-4154-7

Ejemplares similares